Markets
← Back to Stocks
MET
METLIFE INC
Financials · Life & Health Insurance
$68.60
+0.08%
Vol: 0.1M
Araverus Market Read
Thursday, March 19, 2026
Dividend confirmation and analyst Buy rating provide support amid 6.2% three-month decline
MetLife (MET) traded slightly lower in extended hours with pre-market at $75.74 and after-hours at $75.00, down 0.57% and 0.41% respectively from previous close. The company confirmed a $0.315 Q1 2026 dividend, supporting income investors, while analysts maintained a Moderate Buy consensus with a $92.47 price target indicating 21% upside potential from current levels. The stock has declined 6.2% over the past three months amid challenging market conditions.
Price 50d 200d
Previous Market Reads
2 of 2 days↓
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| BRK.BBERKSHIRE | $481.47 | -0.62% | -4.4% | 22.1x | 0.69 | $1.04T |
| JPMJPMORGAN | $287.86 | +0.04% | -6.2% | 12.3x | 1.06 | $776.7B |
| VVISA | $299.88 | +0.29% | -6.2% | 20.6x | 0.79 | $577.9B |
| MAMASTERCARD | $491.83 | +0.69% | -5.9% | 21.7x | 0.84 | $438.3B |
| BACBANK | $47.00 | +0.36% | -10.4% | 9.5x | 1.26 | $343.3B |
| MSMORGAN | $158.58 | -0.22% | -7.6% | 12.9x | 1.21 | $251.8B |
| GSGOLDMAN | $810.12 | +0.58% | -11.2% | 12.4x | 1.34 | $242.8B |
| WFCWELLS | $76.28 | +0.12% | -12.6% | 9.6x | 1.07 | $239.8B |
| AXPAMERICAN | $295.36 | +0.33% | -14.4% | 14.6x | 1.15 | $203.2B |
Fundamentals
Market Cap$45.2B
P/E (TTM)14.6
Forward P/E6.3
Beta0.74
Div Yield331.00%
Prev Close$68.55
RSI (14-Day)
33Neutral
0305070100
52-Week Range
$65.21$68.60$85.00
From High-19.3%
From Low+5.2%
Moving Averages
50d SMA
$75.18-8.8%
200d SMA
$77.19-11.1%
Price below 200d MA — bearish structure.
Returns
1W
-0.3%
1M
-13.4%
3M
-16.0%
6M
-11.6%
1Y
-13.5%
YTD
-14.0%
Volume
Today111K
20d Avg4.3M
Ratio0.03x